Dr. Kevin Dalby is a professor of chemical biology and medicinal chemistry in the College of Pharmacy, and Department of Oncology at The University of Texas in Austin. He is studying the mechanisms of cancer cell signaling to develop targeted therapeutics. The Cancer Prevention and Research Institute of Texas (CPRIT) and the National Institutes of Health, recognized Dr. Dalby's efforts by granting him nearly $5 million to support his research.
Kevin Dalby has been interested in the “why” of chemical reactions since he was a student at the University of Cambridge, where he graduated with a Doctor of Philosophy degree in Organic Chemistry. This curiosity has led to his interest in the processes of cell signaling, and ultimately to cancer research. Dr. Dalby's research areas include biochemistry, cancer, cell biology, chemical biology, drug discovery & diagnostics, and enzymology.
He is a director of The Targeted Therapeutic Drug Discovery & Development Program (TTP), and the principal investigator on a CPRIT core facility grant that gives Texas scientists access to resources for drug discovery research. By understanding cancer cell signaling, Dr. Dalby works to improve diagnoses and utilize technological advances to develop targeted pharmaceuticals for different cancers.
When he is not working, Kevin Dalby enjoys photography and spending time in the Texas countryside with his dogs.